Live attenuated measles vaccine expressing HIV-1 Gag virus like particles covered with gp160ΔV1V2 is strongly immunogenic
Authors:
- Arnaud MorisAMArnaud Moris
- Chantal CombredetCCChantal Combredet
- Valérie NajburgVNValérie Najburg
- Claude RuffiéCRClaude Ruffié
- Michèle FévrierMFMichèle Février
- Nadège CayetNCNadège Cayet
- Samantha BrandlerSBSamantha Brandler
- Olivier SchwartzOSOlivier Schwartz
- Frédéric TangyFTFrédéric Tangy
Abstract
No abstract availableKeywords
This publication has 76 references indexed in Scilit:
- Macaques vaccinated with live-attenuated SIV control replication of heterologous virusJournal of Experimental Medicine, 2008
- Induction of neutralising antibodies and cellular immune responses against SARS coronavirus by recombinant measles virusesVaccine, 2008
- The failed HIV Merck vaccine study: a step back or a launching point for future vaccine development?Journal of Experimental Medicine, 2008
- Pediatric Measles Vaccine Expressing a Dengue Antigen Induces Durable Serotype-specific Neutralizing Antibodies to Dengue VirusPLOS Neglected Tropical Diseases, 2007
- Long-Term Control of Simian Immunodeficiency Virus Replication with Central Memory CD4 + T-Cell Preservation after Nonsterile Protection by a Cytotoxic T-Lymphocyte-Based VaccineJournal of Virology, 2007
- Immune mechanisms associated with protection from vaginal SIV challenge in rhesus monkeys infected with virulence‐attenuated SHIV 89.6Journal of Medical Primatology, 2005
- Production and Characterization of Simian-Human Immunodeficiency Virus-Like ParticlesAIDS Research and Human Retroviruses, 2000
- Studies on processing, particle formation, and immunogenicity of the HIV-1gag gene product: a possible component of a HIV vaccineArchives of Virology, 1992
- Ted Slavin's Blood and the Development of HBV VaccineNew England Journal of Medicine, 1985
- Beitrag zur kollektiven Behandlung pharmakologischer ReihenversucheNaunyn-Schmiedeberg's Archives of Pharmacology, 1931